Drug Trial Radar · NCT00853606
Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction
Last checked: Nov 20, 2026Latest source record: Aug 17, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
712
Actual
Start
Mar 2009
Primary completion
Apr 2010
Study completion Apr 2010
Sponsor
- Lead sponsor
- VIVUS LLCIndustry
- Sponsor type
- Industry
- First posted
- Mar 2, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This open-label study is being conducted to evaluate the long-term safety, tolerability, and efficacy of avanafil in men with mild to severe erectile dysfunction. Approximately 400 subjects will be enrolled and treated with avanafil for up to 52 weeks.
Conditions
- Erectile Dysfunction
Interventions
avanafilDrug
All subjects will initially be assigned to treatment with avanafil 100 mg. Subjects who are unable to tolerate treatment with 100 mg may undergo dose reduction to 50 mg. Subjects who tolerate avanafil 100 mg but who desire increased efficacy may request a dose increase to 200 mg.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Percentage of Sexual Attempts in Which Subjects Were Able to Maintain an Erection of Sufficient Duration to Have Successful Intercourse.Time frame: Baseline, 52 weeks
- Change in Percentage of Sexual Attempts in Which Subjects Were Able to Insert the Penis Into the Partner's VaginaTime frame: Baseline, 52 weeks
- Change in International Index of Erectile Function - Erectile Function Domain (IIEF-EF) ScoreTime frame: Baseline, End of Treatment
Locations
40 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Homewood, Alabama
Research Site
Tucson, Arizona
Research Site
Sacramento, California
Research Site
San Diego, California
Research Site
San Diego, California
Research Site
Waterbury, Connecticut
Research Site
Clearwater, Florida
Research Site
Clearwater, Florida
Research Site
Coral Gables, Florida
Research Site
Hialeah, Florida
Research Site
Jacksonville, Florida
Research Site
Jupiter, Florida
Research Site
Ocala, Florida
Research Site
Pembroke Pines, Florida
Research Site
Ponte Vedra, Florida
Research Site
Tampa, Florida
Research Site
Sandy Springs, Georgia
Research Site
Wichita, Kansas
Research Site
Madisonville, Kentucky
Research Site
Shreveport, Louisiana
Research Site
Kansas City, Missouri
Research Site
Lawrenceville, New Jersey
Research Site
Albany, New York
Research Site
New York, New York
Research Site
Cary, North Carolina
Research Site
Charlotte, North Carolina
Research Site
Charlotte, North Carolina
Research Site
Harrisburg, North Carolina
Research Site
Hickory, North Carolina
Research Site
Raleigh, North Carolina
Research Site
Salisbury, North Carolina
Research Site
Wilmington, North Carolina
Research Site
Winston-Salem, North Carolina
Research Site
Cleveland, Ohio
Research Site
Bala-Cynwyd, Pennsylvania
Research Site
Lancaster, Pennsylvania
Research Site
El Paso, Texas
Research Site
Houston, Texas
Research Site
Spring, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.